Pitcairn’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,645
| Closed | -$260K | – | 753 |
|
|
2024
Q2 | $260K | Buy |
+1,645
| New | +$260K | 0.02% | 625 |
|
|
2023
Q4 | – | Sell |
-2,822
| Closed | -$342K | – | 695 |
|
|
2023
Q3 | $342K | Buy |
2,822
+21
| +0.7% | +$2.55K | 0.03% | 460 |
|
|
2023
Q2 | $321K | Sell |
2,801
-2,697
| -49% | -$309K | 0.03% | 491 |
|
|
2023
Q1 | $758K | Sell |
5,498
-719
| -12% | -$99.1K | 0.07% | 249 |
|
|
2022
Q4 | $806K | Sell |
6,217
-276
| -4% | -$35.8K | 0.08% | 219 |
|
|
2022
Q3 | $718K | Sell |
6,493
-847
| -12% | -$93.7K | 0.08% | 222 |
|
|
2022
Q2 | $550K | Buy |
7,340
+68
| +0.9% | +$5.1K | 0.06% | 276 |
|
|
2022
Q1 | $568K | Buy |
7,272
+1,047
| +17% | +$81.8K | 0.05% | 318 |
|
|
2021
Q4 | $561K | Sell |
6,225
-603
| -9% | -$54.3K | 0.04% | 339 |
|
|
2021
Q3 | $631K | Sell |
6,828
-947
| -12% | -$87.5K | 0.04% | 283 |
|
|
2021
Q2 | $604K | Buy |
7,775
+4,637
| +148% | +$360K | 0.04% | 285 |
|
|
2021
Q1 | $234K | Buy |
3,138
+1,151
| +58% | +$85.8K | 0.02% | 550 |
|
|
2020
Q4 | $339K | Sell |
1,987
-181
| -8% | -$30.9K | 0.03% | 401 |
|
|
2020
Q3 | $305K | Sell |
2,168
-291
| -12% | -$40.9K | 0.03% | 370 |
|
|
2020
Q2 | $394K | Buy |
2,459
+285
| +13% | +$45.7K | 0.04% | 278 |
|
|
2020
Q1 | $213K | Sell |
2,174
-642
| -23% | -$62.9K | 0.03% | 389 |
|
|
2019
Q4 | $363K | Buy |
+2,816
| New | +$363K | 0.03% | 334 |
|
|
2019
Q3 | – | Sell |
-1,885
| Closed | -$286K | – | 549 |
|
|
2019
Q2 | $286K | Sell |
1,885
-134
| -7% | -$20.3K | 0.03% | 409 |
|
|
2019
Q1 | $240K | Buy |
+2,019
| New | +$240K | 0.03% | 438 |
|